| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8778302 | European Urology | 2018 | 9 Pages |
Abstract
In this study, we found that low-prostate-specific antigen, high-grade prostate cancer has a very high risk for prostate cancer death, may not respond well to androgen deprivation therapy, and is associated with neuroendocrine genomic features. These findings suggest that current nomograms and treatment paradigms may need modification.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Brandon A. Mahal, David D. Yang, Natalie Q. Wang, Mohammed Alshalalfa, Elai Davicioni, Voleak Choeurng, Edward M. Schaeffer, Ashley E. Ross, Daniel E. Spratt, Robert B. Den, Neil E. Martin, Kent W. Mouw, Peter F. 3rd, Toni K. Choueiri, Mary-Ellen Taplin,